CoChat

Muscular and cardiorespiratory effects of pseudoephedrine in human athletes

Open access
Gill, Nicholas D., Shield, Anthony, Blazevich, Anthony J., Zhou, Shi, Weatherby, Robert P. · 2000 · British Journal of Clinical Pharmacology
Cited by 63

The DOI matches its Crossref record.

Abstract

Aims Pseudoephedrine (PSE) is a readily available over‐the‐counter nasal decongestant which is structurally similar to amphetamine and is included on the International Olympic Committee's list of banned substances. However to date, little research has supported its putative ergogenic effect. This study investigated whether a 180 mg dose of PSE ingested 45 min prior to exercise enhanced short‐term maximal exercise performance and/or altered related physiological variables. Methods A randomised, double‐blind, crossover study in 22 healthy male athletes. Results Maximum torque (mean ± s.d., n = 22) produced in an isometric knee extension exercise was 321.1 ± 62.0 Nm (PSE) and 295.7 ± 72.4 Nm (placebo), and peak power obtained on the ‘all‐out’ 30 s cycle test was 1262.5 ± 48.5 W (PSE) and 1228.4 ± 47.1 W (placebo) (P < 0.01, P < 0.03, respectively). Subjects were estimated to be producing 96.9 ± 2.4% of their maximal possible isometric leg extension force after PSE ingestion, but only 95.3 ± 2.4% when PSE was not ingested. Bench press tasks and total work during the cycle test were not affected by the ingestion of PSE. Lung function was altered following ingestion of PSE (P < 0.05) with FEV 1 and FVC significantly increased (P < 0.02, P < 0.01, respectively) although the FEV 1/FVC ratio was not altered. Heart rate was significantly elevated by the ingestion of PSE immediately following the 30 s cycle sprint (P < 0.01) however, lactate concentration was not altered by the ingestion of PSE. Conclusions The administration of a 180 mg dose of PSE increased maximum torque, produced in an isometric knee extension and produced an improvement in peak power during maximal cycle performance, as well as improving lung function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2125.2000.00252.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 63

Metadata

Authors
Gill, N. D., Shield, A., Blazevich, A. J., Zhou, S., & Weatherby, R. P.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2000-09
Volume
50
Issue
3
Pages
205-213
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W1577836356
Cited by
63
References
0
FWCI
13.98
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Muscular and cardiorespiratory effects of pseudoephedrine in human athletes. https://app.cochat.ai/papers/10.1046/j.1365-2125.2000.00252.x
The paper
Gill, N. D., Shield, A., Blazevich, A. J., Zhou, S., & Weatherby, R. P. (2000). Muscular and cardiorespiratory effects of pseudoephedrine in human athletes. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.1365-2125.2000.00252.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.